WO2010103548A2 - Improved method for producing lactic acid and derivative thereof - Google Patents

Improved method for producing lactic acid and derivative thereof Download PDF

Info

Publication number
WO2010103548A2
WO2010103548A2 PCT/IN2010/000146 IN2010000146W WO2010103548A2 WO 2010103548 A2 WO2010103548 A2 WO 2010103548A2 IN 2010000146 W IN2010000146 W IN 2010000146W WO 2010103548 A2 WO2010103548 A2 WO 2010103548A2
Authority
WO
WIPO (PCT)
Prior art keywords
lactic acid
derivative
powder
mtcc
fermentation
Prior art date
Application number
PCT/IN2010/000146
Other languages
French (fr)
Other versions
WO2010103548A3 (en
Inventor
Samir S. Somaiya
Sangeeta Srivastava
Martin Annette
Amol Dive
Original Assignee
Godavari Biorefineries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Godavari Biorefineries Ltd. filed Critical Godavari Biorefineries Ltd.
Publication of WO2010103548A2 publication Critical patent/WO2010103548A2/en
Publication of WO2010103548A3 publication Critical patent/WO2010103548A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/56Lactic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07Bacillus

Definitions

  • the present invention relates to an improved method for producing lactic acid.
  • the invention also relates to the mutagenized strain of microorganism, Bacillus coagulans (MTCC 5454). More in particular, the invention relates to rapid and increased production of lactic acid.
  • the lactic acid produced by the method and strain of the current invention is optically pure.
  • Lactic acid (2-hydroxypropanoic acid), also known as milk acid, is known to play an essential role in several biochemical processes. It is also used in many industries for various purposes. In the food industry it is commonly used as a food additive, as an acidulant and preservative. Similarly it is used in the chemical industry as oxychemicals, green solvents, and specialty chemicals for deliming, metal etching, cosmetic and textile applications.
  • the L (+)-lactic acid isomer is used in the production of dairy products, as an acidulating agent in the food industry, as a mordant in wool dying and, as an intermediate for the production of plasticizer agents, adhesives and pharmaceutical product.
  • the lactic acid is used as a monomer for producing polylactic acid (PLA) for biomedical applications.
  • the polylactic acids have potential applications in the medical field as prosthetic devices and devices for controlled drug delivery in humans. It is also used in food industry for packaging.
  • the polylactic acids are l also used for synthesis of ethanol, a cost efficient alternative fuel source.
  • the plastics made from lactic acids can be substituted for conventional plastics produced from petroleum oil owing to their lower emission of carbon dioxide thus reducing global warming.
  • Lactic acid is commercially produced by fermentation of carbohydrates using microorganisms.
  • Various lactic acid-producing microorganisms have been reported and include lactic acid bacteria of the genera Lactobacillus, Lactococcus, Bacillus, Escherichia coli; yeasts of the genus Saccharomyces, and filamentous fungi of the genus Rhizopus.
  • the optical purity of the lactic acid produced using lactic acid bacteria is low. With other microorganisms the yield is generally low, due to large amount of the by-products formed.
  • the current invention overcomes the problems described above and provides a new and improved strain of bacterium for increased and rapid production of lactic acid. Further the lactic acid produced by the method and strain of the current invention is purer. The invention further discloses the use of inexpensive natural sugar sources, such as sugarcane juice and molasses, as substrate for the production of Lactic acid.
  • a further object of the current invention related to the use of inexpensive natural sugar sources as substrates for the production of lactic acid.
  • the present invention relates to a new and improved method for producing lactic acid and/or derivative thereof by use of the mutagenized strain of Bacillus coagulans (MTCC 5454).
  • the invention also relates to rapid and increased production of lactic acid and/or derivative thereof.
  • the invention further relates to production of lactic acid and/or derivative thereof that is optically pure and can be obtained from inexpensive sources.
  • Figure 1, 2 and 3 represent the percentage of lactic acid (LA) produced from reducing sugar (RS) at various time points by Bacillus coagulans MTCC 5454.
  • Figure 4 represents the percentage of lactic acid (LA) produced from reducing sugar at various time points by native wild type Bacillus coagulans.
  • the present invention provides a method of production of lactic acid and/or derivative thereof, by the microorganism Bacillus coagulans (MTCC 5454) comprising culturing the micro-organism coagulans (MTCC 5454) in a nutrient medium and/or fermentation medium according to the invention.
  • MTCC 5454 microorganism Bacillus coagulans
  • the lactic acid "derivative" as used herein refers to any compound modified in at least one chemical element and/or group compared to Lactic acid of the invention. However, the derivative expresses a biological activity similar to and/or the same as that of Lactic acid.
  • the Lactic acid derivative may be obtained by further modifying the microorganism strain of the present invention and/or modifying at least one step of the process of Lactic acid preparation. Accordingly, any reference to Lactic acid encompasses any possible Lactic acid derivative and/or similar compound.
  • MTCC 5454 Bacillus coagulans
  • a culture comprising of a micro-organism of species Bacillus coagulans (MTCC 5454), wherein the Bacillus coagulans (MTCC 5454) is mutagenized strain.
  • the strain may be capable of producing lactic acid and/or derivative thereof in an aqueous nutrient culture medium and/or fermenting medium.
  • the culture comprising mutagenized Bacillus coagulans (MTCC 5454) may be capable of higher production of Lactic acid and/or derivative thereof compared to wild type strain.
  • the microorganism used in the current invention was isolated from soil samples collected from the vicinity of Sakarwadi distillery, located at, Ahmednagar, Maharashtra, India and cultured by standard culture procedures known in the art.
  • the strain was cultured in a medium appropriate for the production of lactic acid.
  • the microorganism was identified as Bacillus coagulans based on the taxonomic characteristics.
  • the isolated microorganism is Gram-positive, spore-forming, motile rods, 0.9 micrometer by 3.0 micrometer to 5.0 micrometer in size, aerobic to microaerophilic as all other species of its genus.
  • S. coagulans forms endospores, resistant to chemical and physical agents.
  • B.coagulans was mutagenized by ultra violet mutation (dark repair mechanism).
  • mutagenesis Any other methods mutagenesis known in the art may also be used and will fall within the scope of the invention.
  • the ultra violet method of mutagenesis was chosen in the current invention for introducing random mutations. Mutagenized isolates are subjected to enrichment, biochemical characterisation and productivity of lactic acid was checked.
  • a strain capable of producing more lactic acid as analyzed by HPLC method was selected and subjected to several generations of culture passages to attain stability.
  • the yield of Lactic acid was analyzed by HPLC however, other methods for analysis of the lactic acid yield known in the art may also be used and shall fall within the scope of the current invention.
  • the new strain thus selected was deposited with Microbial Type Culture Collection and gene bank (MTCC), at Institute of Microbial Technology (IMTECH), Sector39-A, Chandigarh, India.
  • MTCC 5454 The deposit number is MTCC 5454.
  • the new mutagenized strain Bacillus coagulans MTCC 5454 provided by the invention was identified based on biochemical test (Table I).
  • the aqueous nutrient culture medium and/or fermenting medium may comprise
  • the "culture medium” may be the conventional media used for Bacillus spp. or any known media in the field.
  • the said medium may comprise carbon source and nitrogen source and/or carbon source.
  • the "fermentation medium” may further contain other organic and/or in-organic materials so as to accelerate growth of the microorganism and conversion of carbon to lactic acid to increase the rate of lactic acid production.
  • the carbon source may be selected from the group consisting of glucose, maltose, fructose, glycerol, starch, lactose, galactose, sugarcane juice, jaggery, molasses, sugarbeet, wheat, potatoes, rice and sweet sorghum, wherein the carbon source may be 20%.
  • the Nitrogen source may be selected from the group consisting of peanut, powder of soybean, corn, yeast powder, peptone, whey, yeast extract, ammonium nitrate, and/or ammonium chloride, casein, malt extract and Soya, wherein the nitrogen source may be atleast 0.1%(w/v), atleast 0.25%(w/v), atleast 0.5% (w/v), atleast 1% (w/v).
  • Sugar medium such as sugarcane juice, sugar and/or molasses are the most preferred carbon source as they are easily available for lactic acid production.
  • Sugar cane juice may be used being a natural and inexpensive starting material. Therefore aqueous nutrient and/or fermentation medium of the present invention is highly economical compared to sugars used in conventional methods.
  • the growth substrate that may be used may be selected from but not limiting to inexpensive materials, such as peptone, soy, corn, whey, potatoes, rice, molasses of beet-sugar corn steep liquor and yeast extract, can be used as side starting materials.
  • the concentration of proteinaceous and/or micronutrients in fermentation media may be about 1% to 2%.
  • the fermentation media may also contain pH regulators, such as acids preferably, sulphuric acid, alkali such as calcium carbonate, calcium hydroxide, caustic soda.
  • the fermentation medium may further comprise inorganic nutrients like phosphate, magnesium salts such as magnesium sulphate, ferric salts such as ferrous sulphate, ferric chloride, potassium salts such as potassium di- hydrogen phosphate but not limited to these.
  • the fermentation medium may further comprise, but not limited to, trace minerals, such as boric acid, potassium iodide, cobalt dichloride, zinc sulphate, manganese sulphate.
  • the fermentation medium may also comprise, inducers, such as methyl jasmonic acid, arachidonic acid, aminocitrate, ferric ammonium nitrate, potassium permanganate, pyruvic acid, p-coumaric acid, vanadic sulfate, hippuric acid, ⁇ -naphthylacetic acid, 6-benzylamine purine, silver nitrate, and cinnamic acid but should not be considered to be limiting to these.
  • the fermentation medium may also comprise but not limited to precursors, such as phenylalanine, benzamide, sodium benzoate, sodium acetate, propionamide, benzoic acid, and acetamide.
  • the aqueous nutrient culture medium and/or fermenting medium may further comprise glucose, maltose, fructose, glycerol, starch, lactose, galactose, powder of peanut, powder of soybean, corn steep solid, yeast powder, peptone, yeast extract, ammonium nitrate, and/or ammonium chloride for growth of Bacillus coagulans (MTCC 5454). .
  • the method of production of Lactic acid and/or a derivative thereof may be by fermentation and/or conversion of carbon source.
  • the fermentation may be carried out at 40-50 ° C and at a pH of 5 - 7. More in particular, the fermentation may be carried out for about 30 hours.
  • the culture may be subjected to conventional and/or known fermentation conditions in the art.
  • the fermentation may be under anaerobic conditions at the temperature of at least 40°C.
  • the temperature may be in the range of at least 40-50°C.
  • the fermenting pH value may be at least 5.0.
  • the pH may be in the range of 5.0-7.0.
  • the pH value may be adjusted in the mid and late phases of fermentation.
  • Bacillus coaaulans may be cultured by batch fermentation methods for production of lactic acid.
  • the fermentation may be carried in stirred tank reactor and/or use of known apparatus, conditions and/or methods known in the art, for example, oscillating the bottle under a speed rate known for the particular apparatus, condition and/or method.
  • the fermentation may also be carried out in conventional fermentation tanks, such as the 7L and 50L tanks.
  • Bacillus coaaulans (MTCC 5454) is facultative anaerobe (microaerophilic) so it does not require strict anaerobic conditions, it grows well in stirred tank reactor.
  • the fermentor may be inoculated with an established culture of microorganism Bacillus coaaulans (MTCC 5454).
  • the Lactic acid and/or derivative thereof may be recovered by any methods known in the art. In particular membrane separation, ion exchange, solvent extraction, electro dialysis and/or precipitation of lactate salts methods may be used.
  • the productivity of Lactic acid and/or derivative thereof, obtained using the current strain and/or methods of the present invention may be in the range of 4-6g/L/Hr. In particular the lactic acid productivity may be at least 4.5 g/L/Hr. In particular, the Lactic acid and/or derivative thereof thus obtained may be at least 99% pure.
  • the optically pure lactic acid and/or derivative thereof may be L - Lactic acid.
  • the method according to the invention is of shorter cycle, lower cost, and higher production rate. Further, it allows an efficient mass production of Lactic acid if it is used in industry. Its industrial application cannot only protect natural resources, but satisfies the requirement of the Lactic acid demand as well.
  • An essential feature of the invention is that, the strain Bacillus coag ⁇ lans MTCC 5454 in culture is capable of higher conversion of the carbon sources, thus capable of producing higher yield of lactic acid. Therefore the current invention solves an essential problem of low yield and offers an advantage over microbial fermentation methods available in the prior art.
  • the technology of the current invention may be characterized by a short cycle, low cost, and high fermentation rate. The method gives increased yield in 30 hrs. Therefore the lactic acid production method described herein may be applied for industrial production.
  • the use of natural sugar sources as substrate for conversion to lactic acid contributes to protecting the natural environments yet being able to meet the demand.
  • the Bacillus coagulans_(MJCC 5454) mutant strain was first grown onto agar slants. The microorganism was then inoculated into three screw cap tubes containing 10 -15ml of MRS broth. The tubes were incubated at a temperature ranging from 40-50 0 C for 24-36 hrs in a shaker at 150 rpm. 50ml of the above inoculum was added to a 1000 ml flask containing 450 ml of fermentation media prepared by conventional acid hydrolysis of molasses with an initial reducing sugar (RS) content of 15.1% along with micronutrients 1% peptone, 0.05%
  • RS initial reducing sugar
  • Lactic acid (LA) thus produced was isolated and analyzed by the standard practice. The volumetric productivity of lactic acid was found to be 4.5g/L/Hr. Lactic Acid was purified by conventional method for obtaining 99.9% optically pure L-lactic acid.
  • the Bacillus coagulans (MTCC 5454) mutant strain was first grown onto agar slants. The microorganism was then inoculated into screw cap tubes containing 5 ml of MRS broth. The tubes were incubated at a temperature ranging from 40-50 0 C for 24-36 hrs in a shaker at 150 rpm.
  • the 45 ml of the above inoculum was added to a 1000 ml flask containing 450 ml of fermentation media prepared by conventional acid hydrolysis of molasses with an initial reducing sugar (RS) content of 15.6% along with micronutrients 1% yeast extract, 0.5% MgSO 4 ,0.2% MnSO 4 , 2% Ca(OH) 2 and 6.5% CaCO 3 and incubated at 46° C for 31 hrs.
  • the pH was maintained at 5.5.
  • the concentration of lactic acid produced was 15.4%. Lactic acid thus produced was isolated and analyzed by the standard practice.
  • the volumetric productivity of lactic acid was found to be 4.9g/L/Hr. Lactic Acid was purified by conventional method for obtaining 99.9% optically pure L-lactic acid.
  • the Bacillus coagulans (MTCC 5454) mutant strain was first grown onto agar slants. The microorganism was then inoculated into screw cap tubes containing 5 ml of MRS broth. The tubes were incubated at a temperature ranging from 40-50 0 C for 24-36 hrs in a shaker at 150 rpm.
  • the 45 ml of the above inoculum was added to a 1000 ml flask containing 450 ml of fermentation media prepared by conventional acid hydrolysis of molasses with an initial reducing sugar (RS) content of 15.8 % along with micronutrients 1% yeast extract, 0.5% MgSO 4 , 0.2% MnSO 4 , 2% Ca(OH) 2 and 6.5% CaCO 3 and incubated at 48° C for 30 hrs.
  • the pH was maintained at 5.5.
  • the concentration of lactic acid produced was 15%. Lactic acid thus produced was isolated and analyzed by the standard practice.
  • the volumetric productivity of lactic acid was found to be 5g/L/Hr. Lactic Acid was purified by conventional method for obtaining 99.9% optically pure L-lactic acid.
  • the Bacillus coag ⁇ lans wild type strain was first grown onto agar slants. The microorganism was then inoculated into screw cap tubes containing 15 ml of MRS broth. The tubes were incubated at a temperature ranging from 40-50 0 C for 24-36 hrs in a shaker at 150 rpm.
  • the 45 ml of the above inoculum was added to a 1000 ml flask containing 450 ml of fermentation media prepared by conventional acid hydrolysis of molasses with an initial reducing sugar (RS) content of 11.57% along with micronutrients 1% peptone, 0.05% MgSO 4 , 0.02% MnSO 4 , 2% Ca(OH) 2 and 6.5% CaCO 3 and fermented at 49° C for 45 hrs.
  • the pH was maintained at 5.5.
  • the concentration of lactic acid was found to be 11.5 %.
  • the volumetric productivity of lactic acid was 2.6 g/L/Hr.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides a mutagenized strain of Bacillus coagulans, MTCC 5454, and discloses its use in the production of Lactic acid. The invention also provides an efficient, rapid method for increased production of lactic by using the strain MTCC 5454. The present invention uses inexpensive natural sugars as carbon source for conversion to lactic acid.

Description

TITLE
IMPROVED METHOD FOR PRODUCING LACTIC ACID AND DERIVATIVE THEREOF.
FIELD OF THE INVENTION:
The present invention relates to an improved method for producing lactic acid. In particular, the invention also relates to the mutagenized strain of microorganism, Bacillus coagulans (MTCC 5454). More in particular, the invention relates to rapid and increased production of lactic acid. The lactic acid produced by the method and strain of the current invention is optically pure.
BACKGROUND OF THE INVENTION:
Lactic acid (2-hydroxypropanoic acid), also known as milk acid, is known to play an essential role in several biochemical processes. It is also used in many industries for various purposes. In the food industry it is commonly used as a food additive, as an acidulant and preservative. Similarly it is used in the chemical industry as oxychemicals, green solvents, and specialty chemicals for deliming, metal etching, cosmetic and textile applications. The L (+)-lactic acid isomer is used in the production of dairy products, as an acidulating agent in the food industry, as a mordant in wool dying and, as an intermediate for the production of plasticizer agents, adhesives and pharmaceutical product.
Currently there is growing interest in the production of lactic acid for use in synthesis of biodegradable polymer materials. The lactic acid is used as a monomer for producing polylactic acid (PLA) for biomedical applications. The polylactic acids have potential applications in the medical field as prosthetic devices and devices for controlled drug delivery in humans. It is also used in food industry for packaging. The polylactic acids are l also used for synthesis of ethanol, a cost efficient alternative fuel source. Moreover the plastics made from lactic acids can be substituted for conventional plastics produced from petroleum oil owing to their lower emission of carbon dioxide thus reducing global warming.
In view of the benefits described above, the interest in lactic acid have raised progressively. Efforts are evident from the various studies that have focused on the production of lactic acids using various methods and microorganisms. Lactic acid is commercially produced by fermentation of carbohydrates using microorganisms. Various lactic acid-producing microorganisms have been reported and include lactic acid bacteria of the genera Lactobacillus, Lactococcus, Bacillus, Escherichia coli; yeasts of the genus Saccharomyces, and filamentous fungi of the genus Rhizopus. However, the optical purity of the lactic acid produced using lactic acid bacteria is low. With other microorganisms the yield is generally low, due to large amount of the by-products formed. For example, it is observed that both native and recombinant yeast strains produce large amount of ethanol, whereas filamentous fungus produces large amount of glycerol, ethanol and fumaric acid. Although production of Lactic acid from various sugars is also known in the art, the methods described are more expensive, require very long period for fermentation and productivities are low.
Based on the current status of production, supply and demand of Lactic acid, there is a need for an alternative and more efficient lactic acid producing strain of microorganism and method for production of lactic acid. Furthermore there is urgent need in the art for the production of purer forms of lactic acid. The current invention overcomes the problems described above and provides a new and improved strain of bacterium for increased and rapid production of lactic acid. Further the lactic acid produced by the method and strain of the current invention is purer. The invention further discloses the use of inexpensive natural sugar sources, such as sugarcane juice and molasses, as substrate for the production of Lactic acid.
DISCLOSURE OF THE INVENTION:
It is the object of the present invention to provide a method of producing lactic acid and/or derivative thereof by the use of the mutagenized strain of Bacillus coagulans (MTCC 5454).
It is further the object of the present invention to provide a rapid and increased production of lactic acid and/or derivative thereof.
It is yet another object of the invention to produce optically pure form of lactic acid and/or derivative thereof.
A further object of the current invention related to the use of inexpensive natural sugar sources as substrates for the production of lactic acid.
SUMMARY OF THE INVENTION:
The present invention relates to a new and improved method for producing lactic acid and/or derivative thereof by use of the mutagenized strain of Bacillus coagulans (MTCC 5454). The invention also relates to rapid and increased production of lactic acid and/or derivative thereof. The invention further relates to production of lactic acid and/or derivative thereof that is optically pure and can be obtained from inexpensive sources. BRIEF DESCRIPTION OF THE FIGURES;
Figure 1, 2 and 3 represent the percentage of lactic acid (LA) produced from reducing sugar (RS) at various time points by Bacillus coagulans MTCC 5454.
Figure 4 represents the percentage of lactic acid (LA) produced from reducing sugar at various time points by native wild type Bacillus coagulans.
DETAILED DESCRIPTION OF THE INVENTION:
The present invention provides a method of production of lactic acid and/or derivative thereof, by the microorganism Bacillus coagulans (MTCC 5454) comprising culturing the micro-organism coagulans (MTCC 5454) in a nutrient medium and/or fermentation medium according to the invention.
The lactic acid "derivative" as used herein refers to any compound modified in at least one chemical element and/or group compared to Lactic acid of the invention. However, the derivative expresses a biological activity similar to and/or the same as that of Lactic acid. The Lactic acid derivative may be obtained by further modifying the microorganism strain of the present invention and/or modifying at least one step of the process of Lactic acid preparation. Accordingly, any reference to Lactic acid encompasses any possible Lactic acid derivative and/or similar compound.
According to one aspect of the current invention there is provided a micro-organism, Bacillus coagulans (MTCC 5454).
According to another aspect of the current invention there is provided a culture comprising of a micro-organism of species Bacillus coagulans (MTCC 5454), wherein the Bacillus coagulans (MTCC 5454) is mutagenized strain. The strain may be capable of producing lactic acid and/or derivative thereof in an aqueous nutrient culture medium and/or fermenting medium. The culture comprising mutagenized Bacillus coagulans (MTCC 5454) may be capable of higher production of Lactic acid and/or derivative thereof compared to wild type strain.
The microorganism used in the current invention was isolated from soil samples collected from the vicinity of Sakarwadi distillery, located at, Ahmednagar, Maharashtra, India and cultured by standard culture procedures known in the art. The strain was cultured in a medium appropriate for the production of lactic acid. The microorganism was identified as Bacillus coagulans based on the taxonomic characteristics. The isolated microorganism is Gram-positive, spore-forming, motile rods, 0.9 micrometer by 3.0 micrometer to 5.0 micrometer in size, aerobic to microaerophilic as all other species of its genus. S. coagulans forms endospores, resistant to chemical and physical agents. B.coagulans was mutagenized by ultra violet mutation (dark repair mechanism). Any other methods mutagenesis known in the art may also be used and will fall within the scope of the invention. The ultra violet method of mutagenesis was chosen in the current invention for introducing random mutations. Mutagenized isolates are subjected to enrichment, biochemical characterisation and productivity of lactic acid was checked.
After several generations of mutations, a strain capable of producing more lactic acid as analyzed by HPLC method was selected and subjected to several generations of culture passages to attain stability. The yield of Lactic acid was analyzed by HPLC however, other methods for analysis of the lactic acid yield known in the art may also be used and shall fall within the scope of the current invention. The new strain thus selected was deposited with Microbial Type Culture Collection and gene bank (MTCC), at Institute of Microbial Technology (IMTECH), Sector39-A, Chandigarh, India. The deposit number is MTCC 5454.
The new mutagenized strain Bacillus coagulans MTCC 5454 provided by the invention was identified based on biochemical test (Table I).
TABLE 1
Figure imgf000007_0001
According to yet another aspect of the invention there is provided a method for production of lactic acid and/or derivative thereof, comprising
a) Culturing the microorganism Bacillus coagulans (MTCC 5454) in an aqueous nutrient culture medium and/or fermenting medium; and
b) recovering lactic acid from the fermentation broth.
The aqueous nutrient culture medium and/or fermenting medium may comprise
a) at least one carbon source; and
b) at least one nitrogen source; and/or
c) micro-nutrients and/or trace minerals; The "culture medium" may be the conventional media used for Bacillus spp. or any known media in the field. The said medium may comprise carbon source and nitrogen source and/or carbon source. The "fermentation medium" may further contain other organic and/or in-organic materials so as to accelerate growth of the microorganism and conversion of carbon to lactic acid to increase the rate of lactic acid production. The carbon source may be selected from the group consisting of glucose, maltose, fructose, glycerol, starch, lactose, galactose, sugarcane juice, jaggery, molasses, sugarbeet, wheat, potatoes, rice and sweet sorghum, wherein the carbon source may be 20%.. The Nitrogen source may be selected from the group consisting of peanut, powder of soybean, corn, yeast powder, peptone, whey, yeast extract, ammonium nitrate, and/or ammonium chloride, casein, malt extract and Soya, wherein the nitrogen source may be atleast 0.1%(w/v), atleast 0.25%(w/v), atleast 0.5% (w/v), atleast 1% (w/v).
Sugar medium such as sugarcane juice, sugar and/or molasses are the most preferred carbon source as they are easily available for lactic acid production. Sugar cane juice may be used being a natural and inexpensive starting material. Therefore aqueous nutrient and/or fermentation medium of the present invention is highly economical compared to sugars used in conventional methods. In other embodiments, the growth substrate that may be used, may be selected from but not limiting to inexpensive materials, such as peptone, soy, corn, whey, potatoes, rice, molasses of beet-sugar corn steep liquor and yeast extract, can be used as side starting materials. The concentration of proteinaceous and/or micronutrients in fermentation media may be about 1% to 2%. The fermentation media may also contain pH regulators, such as acids preferably, sulphuric acid, alkali such as calcium carbonate, calcium hydroxide, caustic soda. The fermentation medium may further comprise inorganic nutrients like phosphate, magnesium salts such as magnesium sulphate, ferric salts such as ferrous sulphate, ferric chloride, potassium salts such as potassium di- hydrogen phosphate but not limited to these. The fermentation medium may further comprise, but not limited to, trace minerals, such as boric acid, potassium iodide, cobalt dichloride, zinc sulphate, manganese sulphate. The fermentation medium may also comprise, inducers, such as methyl jasmonic acid, arachidonic acid, aminocitrate, ferric ammonium nitrate, potassium permanganate, pyruvic acid, p-coumaric acid, vanadic sulfate, hippuric acid, α-naphthylacetic acid, 6-benzylamine purine, silver nitrate, and cinnamic acid but should not be considered to be limiting to these. The fermentation medium may also comprise but not limited to precursors, such as phenylalanine, benzamide, sodium benzoate, sodium acetate, propionamide, benzoic acid, and acetamide.
The aqueous nutrient culture medium and/or fermenting medium may further comprise glucose, maltose, fructose, glycerol, starch, lactose, galactose, powder of peanut, powder of soybean, corn steep solid, yeast powder, peptone, yeast extract, ammonium nitrate, and/or ammonium chloride for growth of Bacillus coagulans (MTCC 5454). .
The method of production of Lactic acid and/or a derivative thereof may be by fermentation and/or conversion of carbon source. In particular the fermentation may be carried out at 40-50 ° C and at a pH of 5 - 7. More in particular, the fermentation may be carried out for about 30 hours.
The culture may be subjected to conventional and/or known fermentation conditions in the art. The fermentation may be under anaerobic conditions at the temperature of at least 40°C. In particular the temperature may be in the range of at least 40-50°C. The fermenting pH value may be at least 5.0. In particular the pH may be in the range of 5.0-7.0. The pH value may be adjusted in the mid and late phases of fermentation.
Bacillus coaaulans (MTCC 5454) may be cultured by batch fermentation methods for production of lactic acid. The fermentation may be carried in stirred tank reactor and/or use of known apparatus, conditions and/or methods known in the art, for example, oscillating the bottle under a speed rate known for the particular apparatus, condition and/or method. The fermentation may also be carried out in conventional fermentation tanks, such as the 7L and 50L tanks. As Bacillus coaaulans (MTCC 5454) is facultative anaerobe (microaerophilic) so it does not require strict anaerobic conditions, it grows well in stirred tank reactor. The fermentor may be inoculated with an established culture of microorganism Bacillus coaaulans (MTCC 5454).
The Lactic acid and/or derivative thereof may be recovered by any methods known in the art. In particular membrane separation, ion exchange, solvent extraction, electro dialysis and/or precipitation of lactate salts methods may be used. The productivity of Lactic acid and/or derivative thereof, obtained using the current strain and/or methods of the present invention may be in the range of 4-6g/L/Hr. In particular the lactic acid productivity may be at least 4.5 g/L/Hr. In particular, the Lactic acid and/or derivative thereof thus obtained may be at least 99% pure. The optically pure lactic acid and/or derivative thereof may be L - Lactic acid.
The method according to the invention is of shorter cycle, lower cost, and higher production rate. Further, it allows an efficient mass production of Lactic acid if it is used in industry. Its industrial application cannot only protect natural resources, but satisfies the requirement of the Lactic acid demand as well. An essential feature of the invention is that, the strain Bacillus coagυlans MTCC 5454 in culture is capable of higher conversion of the carbon sources, thus capable of producing higher yield of lactic acid. Therefore the current invention solves an essential problem of low yield and offers an advantage over microbial fermentation methods available in the prior art. The technology of the current invention may be characterized by a short cycle, low cost, and high fermentation rate. The method gives increased yield in 30 hrs. Therefore the lactic acid production method described herein may be applied for industrial production. The use of natural sugar sources as substrate for conversion to lactic acid, contributes to protecting the natural environments yet being able to meet the demand.
While the invention has been described with particular reference to certain embodiments thereof, it will be understood that various modifications can be made to the above- mentioned embodiments without departing from the spirit and scope of the present invention. The examples and the particular proportions set forth are intended to be illustrative only.
EXAMPLES
EXAMPLE 1:
The Bacillus coagulans_(MJCC 5454) mutant strain was first grown onto agar slants. The microorganism was then inoculated into three screw cap tubes containing 10 -15ml of MRS broth. The tubes were incubated at a temperature ranging from 40-500C for 24-36 hrs in a shaker at 150 rpm. 50ml of the above inoculum was added to a 1000 ml flask containing 450 ml of fermentation media prepared by conventional acid hydrolysis of molasses with an initial reducing sugar (RS) content of 15.1% along with micronutrients 1% peptone, 0.05%
MgSO4, 0.02% MnSO4, and 6.5% CaCO3 and incubated at 40° C for 35 hrs. The pH was maintained at 5.5. The concentration of lactic acid produced was 14.4%. Lactic acid (LA) thus produced was isolated and analyzed by the standard practice. The volumetric productivity of lactic acid was found to be 4.5g/L/Hr. Lactic Acid was purified by conventional method for obtaining 99.9% optically pure L-lactic acid.
EXAMPLE 2:
The Bacillus coagulans (MTCC 5454) mutant strain was first grown onto agar slants. The microorganism was then inoculated into screw cap tubes containing 5 ml of MRS broth. The tubes were incubated at a temperature ranging from 40-500C for 24-36 hrs in a shaker at 150 rpm. The 45 ml of the above inoculum was added to a 1000 ml flask containing 450 ml of fermentation media prepared by conventional acid hydrolysis of molasses with an initial reducing sugar (RS) content of 15.6% along with micronutrients 1% yeast extract, 0.5% MgSO4 ,0.2% MnSO4, 2% Ca(OH)2 and 6.5% CaCO3 and incubated at 46° C for 31 hrs. The pH was maintained at 5.5. The concentration of lactic acid produced was 15.4%. Lactic acid thus produced was isolated and analyzed by the standard practice. The volumetric productivity of lactic acid was found to be 4.9g/L/Hr. Lactic Acid was purified by conventional method for obtaining 99.9% optically pure L-lactic acid.
EXAMPLE 3:
The Bacillus coagulans (MTCC 5454) mutant strain was first grown onto agar slants. The microorganism was then inoculated into screw cap tubes containing 5 ml of MRS broth. The tubes were incubated at a temperature ranging from 40-500C for 24-36 hrs in a shaker at 150 rpm. The 45 ml of the above inoculum was added to a 1000 ml flask containing 450 ml of fermentation media prepared by conventional acid hydrolysis of molasses with an initial reducing sugar (RS) content of 15.8 % along with micronutrients 1% yeast extract, 0.5% MgSO4, 0.2% MnSO4, 2% Ca(OH)2 and 6.5% CaCO3 and incubated at 48° C for 30 hrs. The pH was maintained at 5.5. The concentration of lactic acid produced was 15%. Lactic acid thus produced was isolated and analyzed by the standard practice. The volumetric productivity of lactic acid was found to be 5g/L/Hr. Lactic Acid was purified by conventional method for obtaining 99.9% optically pure L-lactic acid.
EXAMPLE 4: (Native wild type strain):
The Bacillus coagυlans wild type strain was first grown onto agar slants. The microorganism was then inoculated into screw cap tubes containing 15 ml of MRS broth. The tubes were incubated at a temperature ranging from 40-500C for 24-36 hrs in a shaker at 150 rpm. The 45 ml of the above inoculum was added to a 1000 ml flask containing 450 ml of fermentation media prepared by conventional acid hydrolysis of molasses with an initial reducing sugar (RS) content of 11.57% along with micronutrients 1% peptone, 0.05% MgSO4, 0.02% MnSO4, 2% Ca(OH)2 and 6.5% CaCO3 and fermented at 49° C for 45 hrs. The pH was maintained at 5.5. The concentration of lactic acid was found to be 11.5 %. The volumetric productivity of lactic acid was 2.6 g/L/Hr.

Claims

1. A micro-organism, Bacillus coagulans MTCC 5454.
2. A culture comprising of a micro-organism Bacillus coagulans (MTCC 5454), capable of producing lactic acid and/or derivative thereof in an aqueous nutrient culture medium and/or fermenting medium.
3. The culture according to claim 2, wherein the Bacillus coαgu/αns_(MTCC 5454) is mutagenized and is capable of higher production of Lactic acid and/or derivative thereof compared to wild type strain.
4. The culture according to claim 2 wherein, the aqueous nutrient culture medium and/or fermenting medium comprises
a) at least one carbon source; and
b) at least one nitrogen source; and/or
c) micro-nutrients and/or trace minerals;
5. The culture according to claim 2, wherein the aqueous nutrient culture medium and/or fermenting medium further comprises glucose, maltose, fructose, glycerol, starch, lactose, galactose, powder of peanut, powder of soybean, corn steep solid, yeast powder, peptone, yeast extract, ammonium nitrate, and/or ammonium chloride for growth of Bacillus coagulans (MTCC 5454).
6. The culture according to claim 4, wherein the carbon source is selected from the group consisting of glucose, maltose, fructose, glycerol, starch, lactose, galactose, sugarcane juice, jaggery, molasses, sugarbeet, wheat, potatoes, rice, jowar and sweet sorgham.
7. The cell culture according to claim 4, wherein the Nitrogen source is selected from the group consisting of peanut, powder of soybean, corn, yeast powder, peptone, whey, yeast extract, ammonium nitrate, and/or ammonium chloride, casein, malt extract and Soya.
8. A method for production of lactic acid and/or derivative thereof, comprising
a) Culturing the organism of claim 1 in an aqueous nutrient culture medium and/or fermenting medium; and
b) recovering lactic acid from the fermentation broth.
9. The method according to claim 8 wherein, the aqueous nutrient culture medium and/or fermenting medium comprises
a) at least one carbon source; and
b) at least one nitrogen source; and/or
c) micro-nutrients and/or trace minerals;
10. The method according to claim 8, wherein the aqueous nutrient culture medium and/or fermenting medium further comprises glucose, maltose, fructose, glycerol, starch, lactose, galactose, powder of peanut, powder of soybean, corn steep solid, yeast powder, peptone, yeast extract, ammonium nitrate, and/or ammonium chloride for growth of Bacillus coagulans (MTCC 5454).
11. The method according to claim 9, wherein the carbon source is selected from natural sources comprising glucose, maltose, fructose, glycerol, starch, lactose, galactose, sugarcane juice, jaggery, molasses, sugarbeet, wheat, potatoes, rice and sweet sorghum.
12. The method according to claim 9, wherein the nitrogen source is selected from the group consisting of peanut, powder of soybean, corn, yeast powder, peptone, whey, yeast extract, ammonium nitrate, and/or ammonium chloride, casein, malt extract and Soya.
13. The method according to claim 8, wherein the production of lactic acid and/or a derivative thereof is by fermentation and/or conversion of carbon source.
14. The method according to claim 13, wherein, the fermentation is carried out at 40-50 ° C and at a pH of 5- 7.
15. The method according to claim 13, wherein the fermentation and/or conversion of carbon source is carried out at for about 30 hours.
16. The method according to claim 8, wherein the Lactic acid and/or derivative thereof is recovered by membrane separation, ion exchange, solvent extraction, electro dialysis and/or precipitation of lactate salts.
17. The method according to claim 16, wherein the productivity of Lactic acid and/or derivative thereof, obtained is at least 4.5 g/L/Hr.
18. The method according to claim 17 wherein the Lactic acid and/or derivative thereof is at least 99% optically pure.
19. The method according to claim 18 wherein the optically pure Lactic acid and/or derivative thereof is L-Lactic acid.
20. A method for production of lactic acid and/or derivative thereof as described herein above and illustrated by drawings and example.
PCT/IN2010/000146 2009-03-13 2010-03-12 Improved method for producing lactic acid and derivative thereof WO2010103548A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN553/MUM/2009 2009-03-13
IN553MU2009 2009-03-13

Publications (2)

Publication Number Publication Date
WO2010103548A2 true WO2010103548A2 (en) 2010-09-16
WO2010103548A3 WO2010103548A3 (en) 2011-09-09

Family

ID=42728895

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2010/000146 WO2010103548A2 (en) 2009-03-13 2010-03-12 Improved method for producing lactic acid and derivative thereof

Country Status (1)

Country Link
WO (1) WO2010103548A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102653725A (en) * 2012-05-30 2012-09-05 南京工业大学 Bacillus coagulans and application thereof in mixed fermentation production of L-lactic acid
WO2017072748A1 (en) * 2015-10-30 2017-05-04 Glanbia Ingredients Ireland Limited A method for producing lactic acid by bacterial fermentation
EP3282018A1 (en) 2016-08-08 2018-02-14 Glanbia Ingredients Ireland Designated Activity Company A method of producing lactic acid
CN114015638A (en) * 2021-12-24 2022-02-08 普立思生物科技有限公司 Fermentation medium for producing polymer-grade S-lactic acid
WO2023283821A1 (en) * 2021-07-14 2023-01-19 万华化学集团股份有限公司 Preparation method for and application of lactic acid

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079164A (en) * 1989-03-10 1992-01-07 Jungbunzlauer Aktiengesellschaft Microorganism of the species bacillus ciaguans

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079164A (en) * 1989-03-10 1992-01-07 Jungbunzlauer Aktiengesellschaft Microorganism of the species bacillus ciaguans

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PAYOT ET AL.: 'Lactic acid production by Bacillus coagulans - Kinetic studies and optimization of culture medium for batch and continuous fermentations.' ENZYME AND MICROBIAL TECHNOLOGY vol. 24, 1999, pages 191 - 199 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102653725A (en) * 2012-05-30 2012-09-05 南京工业大学 Bacillus coagulans and application thereof in mixed fermentation production of L-lactic acid
CN102653725B (en) * 2012-05-30 2013-09-04 南京工业大学 Bacillus coagulans and application thereof in mixed fermentation production of L-lactic acid
WO2017072748A1 (en) * 2015-10-30 2017-05-04 Glanbia Ingredients Ireland Limited A method for producing lactic acid by bacterial fermentation
US10927390B2 (en) 2015-10-30 2021-02-23 Glanbia Ireland Designated Activity Company Method for producing lactic acid by bacterial fermentation
EP3282018A1 (en) 2016-08-08 2018-02-14 Glanbia Ingredients Ireland Designated Activity Company A method of producing lactic acid
WO2018029219A1 (en) 2016-08-08 2018-02-15 Glanbia Ireland Dac A method of producing lactic acid
RU2763351C2 (en) * 2016-08-08 2021-12-28 Гланбия Айрленд Дак Method for producing lactic acid
US11382335B2 (en) 2016-08-08 2022-07-12 Glanbia Ireland Dac Method of producing lactic acid
WO2023283821A1 (en) * 2021-07-14 2023-01-19 万华化学集团股份有限公司 Preparation method for and application of lactic acid
CN114015638A (en) * 2021-12-24 2022-02-08 普立思生物科技有限公司 Fermentation medium for producing polymer-grade S-lactic acid

Also Published As

Publication number Publication date
WO2010103548A3 (en) 2011-09-09

Similar Documents

Publication Publication Date Title
Wang et al. Highly efficient production of D-lactate by Sporolactobacillus sp. CASD with simultaneous enzymatic hydrolysis of peanut meal
JP5564426B2 (en) A member of the Pasteurella family that produces carboxylic acids
Nguyen et al. Production of L-lactic acid from a green microalga, Hydrodictyon reticulum, by Lactobacillus paracasei LA104 isolated from the traditional Korean food, makgeolli
AU754069B2 (en) Low PH lactic acid fermentation
Abdel-Rahman et al. Improved lactic acid productivity by an open repeated batch fermentation system using Enterococcus mundtii QU 25
WO2011143800A1 (en) Bacillus coagulans strain used in producing l-lactic acid and use thereof
John et al. Simultaneous saccharification and L-(+)-lactic acid fermentation of protease-treated wheat bran using mixed culture of lactobacilli
Cheng et al. Production of 1, 3-propanediol by Klebsiella pneumoniae from glycerol broth
CN106434483B (en) A kind of lactobacillus buchneri and its application
US11946036B2 (en) Bacterium and obtaining method and application thereof
CN106399195B (en) A kind of Lactobacillus casei and its application
EP1702060B1 (en) A method for producing lactic acid with high concentration and high yield using lactic acid bacteria
WO2010103548A2 (en) Improved method for producing lactic acid and derivative thereof
Ji et al. Enhancing L-malate production of Aspergillus oryzae by nitrogen regulation strategy
JP6521243B2 (en) Method for aerobically producing 3-hydroxybutyric acid or a salt thereof
Tsai et al. Strain screening and development for industrial lactic acid fermentation
TWI577800B (en) Enterococcus faecalis and uses of lactic acid production at high temperatures
CN108384730B (en) Lactobacillus paracasei and application thereof in conversion synthesis of phenyllactic acid
JP2000037196A (en) Ammonia-resistant l(+)-lactic acid productive bacterium and production of l(+)-lactic acid
Lee et al. Improvement of hydroxyvalerate fraction in poly (β-hydroxybutyrate-co-β-hydroxyvalerate) by a mutant strain of Alcaligenes eutrophus
Aboseidah et al. Optimization of lactic acid production by a novel strain, Enterococcus faecalis KY072975 isolated from infants stool in Egypt
CN108587923B (en) Method for improving malic acid fermentation performance
JP2011103879A (en) Method for producing lactic acid
Mirdamadi et al. Lactic acid production by Lactobacillus strains
CN114277065B (en) Method for co-production of lactic acid and succinic acid by mixed fermentation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10750466

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10750466

Country of ref document: EP

Kind code of ref document: A2